Search / 2371 results found

from
to

One-day record for COVID-19 tests

SPRINGFIELD – The Illinois Department of Public Health (IDPH) today reported 21,787 new confirmed and probable cases of coronavirus disease (COVID-19) in Illinois, including 239 additional deaths since reporting last Friday, September 17, 2021.  More than 80% of Illinois adults have received at least one COVID-19 vaccine dose and more than 63%% of Illinois adults are fully vaccinated, according to data from the Centers for Disease Control and Prevention (CDC).  Of Illinois’ total population, almost 68% has received at least one COVID-19 vaccine dose and 53% of Illinois’ total population is fully vaccinated.

Currently, IDPH is reporting a total of 1,612,129 cases, including 24,783 deaths, in 102 counties in Illinois. The age of cases ranges from younger than one to older than 100 years. Since reporting on Friday, September 17, 2021, laboratories have reported 797,018 specimens for a total of 31,192,769.  Yesterday, 150,245 COVID-19 tests were reported; the highest one-day total of COVID-19 tests since the beginning of the pandemic.  As of last night, 1,926 individuals in Illinois were reported to be in the hospital with COVID-19.  Of those, 474 patients were in the ICU and 252 patients with COVID-19 were on ventilators. 

The preliminary seven-day statewide positivity for cases as a percent of total test from September 17-23, 2021 is 2.7%.  The preliminary seven-day statewide test positivity from September 17-23, 2021 is 3.7%. 

A total of 14,419,886 vaccines have been administered in Illinois as of last midnight.  The seven-day rolling average of vaccines administered daily is 19,371 doses.  Since reporting on Friday, September 17, 2021, 135,598 doses were reported administered in Illinois. 

*All data are provisional and will change.  Additional information and COVID-19 data can be found at http://www.dph.illinois.gov/covid19.

Vaccination is the key to ending this pandemic.  To find a COVID-19 vaccination location near you, go to www.vaccines.gov.

  • Updated

GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, hosted HM King Carl XVI Gustaf and HM Queen Silvia for a visit to Novavax AB, the company's Uppsala, Sweden manufacturing affiliate on Thursday, September 23. The visit included a discussion of NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate, and the company's role in combatting the global pandemic.

  • Updated

GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, hosted HM King Carl XVI Gustaf and HM Queen Silvia for a visit to Novavax AB, the company's Uppsala, Sweden manufacturing affiliate on Thursday, September 23. The visit included a discussion of NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate, and the company's role in combatting the global pandemic.